Teacher Retirement System of Texas Acquires 11,070 Shares of STERIS plc $STE

Key Points

• Teacher Retirement System of Texas increased its stake in STERIS by 85.9% in Q4, buying an additional 11,070 shares to own 23,957 shares worth about $6.07 million.
• Director Cynthia L. Feldmann sold 3,098 shares on March 5 at an average $237.21, reducing her holding by 81.46%; insiders now own about 1.07% of the stock.
• STERIS beat quarterly EPS expectations with $2.53 and revenue up 9.2% y/y, set FY2026 guidance at 10.150–10.300 EPS, and holds an average analyst rating of "Moderate Buy" with a $275.20 price target.

Teacher Retirement System of Texas boosted its holdings in shares of STERIS plc (NYSE:STE - Free Report) by 85.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 23,957 shares of the medical equipment provider's stock after buying an additional 11,070 shares during the quarter. Teacher Retirement System of Texas' holdings in STERIS were worth $6,074,000 at the end of the most recent quarter.

Other large investors also recently added to or reduced their stakes in the company. Steigerwald Gordon & Koch Inc. bought a new stake in STERIS during the third quarter valued at approximately $25,000. Board of the Pension Protection Fund bought a new stake in STERIS during the fourth quarter valued at approximately $25,000. Harbor Investment Advisory LLC grew its position in STERIS by 115.4% during the fourth quarter. Harbor Investment Advisory LLC now owns 112 shares of the medical equipment provider's stock valued at $28,000 after buying an additional 60 shares during the period. Cloud Capital Management LLC bought a new stake in STERIS during the third quarter valued at approximately $29,000. Finally, Geneos Wealth Management Inc. grew its position in STERIS by 416.0% during the first quarter. Geneos Wealth Management Inc. now owns 129 shares of the medical equipment provider's stock valued at $29,000 after buying an additional 104 shares during the period. 94.69% of the stock is currently owned by institutional investors.

Insider Buying and Selling at STERIS

In other news, Director Cynthia L. Feldmann sold 3,098 shares of the business's stock in a transaction on Thursday, March 5th. The shares were sold at an average price of $237.21, for a total value of $734,876.58. Following the transaction, the director owned 705 shares of the company's stock, valued at approximately $167,233.05. The trade was a 81.46% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.07% of the stock is currently owned by insiders.

STERIS Stock Performance

STE opened at $221.86 on Monday. The firm has a market cap of $21.76 billion, a P/E ratio of 30.94 and a beta of 1.07. STERIS plc has a 1-year low of $209.98 and a 1-year high of $269.44. The company has a 50 day simple moving average of $228.82 and a two-hundred day simple moving average of $245.35. The company has a debt-to-equity ratio of 0.26, a current ratio of 2.48 and a quick ratio of 1.75.

STERIS (NYSE:STE - Get Free Report) last posted its quarterly earnings results on Wednesday, February 4th. The medical equipment provider reported $2.53 earnings per share for the quarter, hitting analysts' consensus estimates of $2.53. STERIS had a net margin of 12.15% and a return on equity of 14.34%. The company's revenue for the quarter was up 9.2% on a year-over-year basis. During the same period last year, the company earned $2.32 earnings per share. STERIS has set its FY 2026 guidance at 10.150-10.300 EPS. Equities analysts forecast that STERIS plc will post 10.22 earnings per share for the current fiscal year.

STERIS Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Thursday, March 19th. Shareholders of record on Tuesday, February 17th were given a $0.63 dividend. This represents a $2.52 dividend on an annualized basis and a dividend yield of 1.1%. The ex-dividend date was Tuesday, February 17th. STERIS's dividend payout ratio is presently 35.15%.

Wall Street Analysts Forecast Growth

STE has been the subject of a number of recent analyst reports. Wall Street Zen lowered shares of STERIS from a "strong-buy" rating to a "buy" rating in a research report on Sunday. Weiss Ratings lowered shares of STERIS from a "buy (b-)" rating to a "hold (c+)" rating in a research report on Thursday, April 16th. Five investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to MarketBeat, STERIS presently has an average rating of "Moderate Buy" and an average price target of $275.20.

STERIS Company Profile

STERIS Corporation NYSE: STE is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.

Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for STERIS plc (NYSE:STE - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.